Chargement en cours...

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

During the clinical trial development of directly acting antivirals (DAAs), evidence regarding the treatment efficacy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) was scarce because these patients have always been excluded. Apart from the clinical trials, more HCC patients are...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Hepatol
Auteurs principaux: Huang, Chung-Feng, Yu, Ming-Lung
Format: Artigo
Langue:Inglês
Publié: The Korean Association for the Study of the Liver 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589855/
https://ncbi.nlm.nih.gov/pubmed/30739433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2018.1014
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!